The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome

European Journal of Endocrinology

Volumn 168, Issue 6, 2013, Pages 871-877

  Panidis, Dimitrios ^a   Tziomalos, Konstantinos ^a   Papadakis, Efstathios ^a   Chatzis, Panagiotis ^a   Kandaraki, Eleni A ^a   Tsourdi, Elena A ^a   Vosnakis, Christos ^a   Katsikis, Ilias ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; INSULIN; PRASTERONE SULFATE; TESTOSTERONE;

ABDOMINAL OBESITY; ADULT; AGE; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; ANDROGENS; BODY MASS INDEX; FEMALE; HIRSUTISM; HUMANS; OBESITY, ABDOMINAL; POLYCYSTIC OVARY SYNDROME; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84878736332     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0039     Document Type: Article

References (34)

1. Goodarzi MO, Dumesic DA, Chazenbalk G & Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature Reviews. Endocrinology 2011 7 219-231. (doi:10.1038/nrendo.2010.217)
2. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al. Positions statement: criteria fordefining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. Journal of ClinicalEndocrinology andMetabolism2006 914237-4245. (doi:10.1210/jc.2006-0178) (Pubitemid 44833391)
3. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 19 41-47. (doi:10.1093/humrep/deh098) (Pubitemid 38072004)
4. Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, Shapiro J, Montori VM & Swiglo BA. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1105-1120. (doi:10.1210/jc. 2007-2437) (Pubitemid 351519694)
5. Randall VA. Androgens and hair growth. Dermatologic Therapy 2008 21 314-328. (doi:10.1111/j.1529-8019.2008.00214.x)
6. Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, Criscimanna A & Giordano C. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome. European Journal of Endocrinology 2006 155 859-865. (doi:10.1530/eje.1.02290) (Pubitemid 46040625)
7. Guzel AI, Kuyumcuoǧlu U & Celik Y. Factors affecting the degree of hirsutism in patients with polycystic ovary syndrome. Archives of Gynecology and Obstetrics 2012 285 767-770. (doi:10.1007/s00404-011-2077-5)
8. Cosar E, Koken G, Sahin FK, Arioz DT & Yilmazer M. Insulin sensitivity does not differentiate by hirsutism in non-obese women with polycystic ovary syndrome. Endocrine Journal 2008 55 465-468. (doi:10.1507/endocrj.K07-069) (Pubitemid 351949738)
9. Landay M, Huang A & Azziz R. Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS. Fertility and Sterility 2009 92 643-647. (doi:10.1016/j.fertnstert.2008. 06.021)
10. Chang WY, Knochenhauer ES, Bartolucci AA & Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertility and Sterility 2005 83 1717-1723. (doi:10.1016/j.fertnstert.2005.01.096) (Pubitemid 40824804)
11. Falsetti L, Gambera A, Andrico S & Sartori E. Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences. Gynecological Endocrinology 2002 16 275-284. (Pubitemid 34988913)
12. Demir B, Pasa S, Demir S, Tumer C, Atay AE, Gul T & Atamer Y. Hirsutism score and the severity of hyperandrogenism associated with polycystic ovary syndrome in the southeastern region of Turkey. Journal of International Medical Research 2011 39 1529-1535. (doi:10.1177/147323001103900443)
13. Legro RS, Myers ER, Barnhart HX, Carson SA, Diamond MP, Carr BR, SchlaffWD, Coutifaris C, McGovern PG, Cataldo NA et al. The pregnancy in polycystic ovary syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertility and Sterility 2006 86 914-933. (doi:10.1016/j.fertnstert.2006.03.037) (Pubitemid 44485050)
14. Coffey S & Mason H. The effect of polycystic ovary syndrome on health-related quality of life. Gynecological Endocrinology 2003 17 379-386. (doi:10.1080/09513590312331290268) (Pubitemid 37338868)
15. Luque-Ramírez M, Mendieta-Azcona C, Alvarez-Blasco F & Escobar-Morreale HF. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. Human Reproduction 2007 22 3197-3203. (doi:10.1093/humrep/dem324) (Pubitemid 351696785)
16. Christakou CD & Diamanti-Kandarakis E. Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Women's Health 2008 4 583-594. (doi:10.2217/17455057.4.6.583)
17. Hatch R, Rosenfield RL, Kim MH & Tredway D. Hirsutism: implications, etiology, and management. American Journal of Obstetrics and Gynecology 1981 140 815-830. (Pubitemid 11046650)
18. Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, Pugeat M, Qiao J, Wijeyaratne CN, Witchel SF et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Human Reproduction Update 2012 18 146-170. (doi:10.1093/humupd/dmr042)
19. Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S & Panidis D. Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. American Journal of Physiology. Endocrinology and Metabolism 2009 296 E238-E243. (doi:10.1152/ajpendo.90684.2008)
20. CarterGD,Holland SM,Alaghband-Zadeh J, Rayman G, Dorrington- Ward P & Wise PH. Investigation of hirsutism: testosterone is not enough. Annals of Clinical Biochemistry 1983 20 262-263. (Pubitemid 14244990)
21. Matthews D, Hosker J, Rudenski A, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/BF00280883) (Pubitemid 15018832)
22. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G & Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 2402-2410. (doi:10.1210/jc.85.7.2402) (Pubitemid 32269192)
23. Lobo RA, Goebelsmann U & Horton R. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1983 57 393-397. (doi:10.1210/jcem-57-2-393) (Pubitemid 13032496)
24. Norman RJ, Dewailly D, Legro RS & Hickey TE. Polycystic ovary syndrome. Lancet 2007 370 685-697. (doi:10.1016/S0140-6736(07)61345-2) (Pubitemid 47285318)
25. Moran LJ, Hutchison SK, Norman RJ & Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2011 7 CD007506.
26. Yusuf S, Hawken S, Öunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 364 937-952. (doi:10.1016/S0140-6736(04)17018-9) (Pubitemid 39208455)
27. Cosma M, Swiglo BA, Flynn DN, Kurtz DM, Labella ML, Mullan RJ, Elamin MB, Erwin PJ & Montori VM. Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. Journal of Clinical Endocrinology and Metabolism 2008 93 1135-1142. (doi:10.1210/jc.2007-2429) (Pubitemid 351519697)
28. Kumar A, Woods KS, Bartolucci AA & Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clinical Endocrinology 2005 62 644-649. (doi:10.1111/j.1365-2265.2005.02256.x) (Pubitemid 40825931)
29. Panidis D, Tziomalos K, Macut D, Delkos D, Betsas G, Misichronis G & Katsikis I. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome. Fertility and Sterility 2012 97 494-500. (doi:10.1016/j.fertnstert.2011.11.041)
30. Carmina E, Rosato F, Jannì A, Rizzo M & Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 2006 91 2-6. (doi:10.1210/jc.2005-1457) (Pubitemid 43069106)
31. Dilbaz B, Ozkaya E, CinarM, Cakir E & Dilbaz S. Cardiovascular disease risk characteristics of themain polycystic ovarysyndrome phenotypes. Endocrine 2011 39 272-277. (doi:10.1007/s12020-011-9437-6)
32. Welt CK, Gudmundsson JA, Arason G, Adams J, Palsdottir H, Gudlaugsdottir G, Ingadottir G & Crowley WF. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. Journal of Clinical Endocrinology and Metabolism 2006 91 4842-4848. (doi:10.1210/jc.2006-1327) (Pubitemid 44917316)
33. Guastella E, Longo RA & Carmina E. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertility and Sterility 2010 94 2197-2201. (doi:10.1016/j.fertnstert.2010.02.014)
34. Hahn S, Bering van Halteren W, Roesler S, Schmidt M, Kimmig R, Tan S, Mann K & Janssen OE. The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome. Experimental and Clinical Endocrinology & Diabetes 2006 114 175-181. (doi:10.1055/s-2006-924063) (Pubitemid 43845194)